The partnership with Noom aims to cut costs by treating weight management as preventative healthcare. Nearly 2 million Highmark Health members are expected to be eligible for the programs. The ...

At-home health testing platform Ash is expanding its partnership with weight-loss company Noom to bring Noom's Proactive Health Microdose GLP-1Rx Program to market. Noom's program, launched in August, ...

70% of Noom members receiving microdoses of GLP-1 with lifestyle support report no side effects, while experiencing significant weight loss and overall health gains The program addresses all three ...

"Lower dose does not mean lower responsibility." ...

In this episode, MM+M Pharma Editor Lecia Bushak sits down with Noom’s CEO Geoff Cook and Chief Medical Officer Dr. Jeffrey Egler to discuss the launch of their new Microdose GLP-1 program, designed ...

New program pairs microdoses of GLP-1 medication with Noom’s powerful behavior-change program and at-home biomarker testing to track the health impact of combining GLP-1 therapy with healthy habits.

Weight loss company Noom will now be available to employers to purchase directly through Castlight Health's healthcare navigation platform. "From our standpoint, you can have the greatest products in ...

Noom has launched a new Proactive Health GLP-1 Program focused on preventive health care. The program includes at-home testing of 17 biomarkers, behavioral support, and personalized GLP-1 microdosing ...

Ozempic may be more expensive and harder to find now that compounded semaglutide isn’t available. Here are seven reputable ...